|
Roderick de Greef 45 has served on the Company's Board of Directors since November 2003. Mr. de Greef has served as the Chief Financial Officer of Cambridge Heart since October 2005. Mr. de Greef served as the Executive Vice President Chief Financial Officer and Secretary of Cardiac Science Inc. from March 2001 to September 2005. From 1995 to 2001 Mr. de Greef provided corporate finance advisory services to a number of early stage companies including Cardiac Science where he was instrumental in securing equity capital beginning in 1997 and advising on merger and acquisition activity. From 1989 to 1995 Mr. de Greef was Vice President and Chief Financial Officer of BioAnalogics Inc. and International BioAnalogics Inc. both publicly held development stage medical technology companies located in Portland Oregon. From 1986 to 1989 Mr. de Greef was Controller and then Chief Financial Officer of publicly held Brentwood Instruments Inc. Mr. de Greef has a B.A. in Economics and International Relations from California State University at San Francisco and an M.B.A. from the University of Oregon. Mr. de Greef also serves on the boards of BioLife Solutions Inc. a public biotechnology company located in Binghamton New York and DentalView Inc. an Irvine-based privately held medical device company. | 